Foetal Allogeneic Intracerebroventricular Neural Stem Cell Transplantation in People with Secondary Progressive Multiple Sclerosis: A phase I dose-escalation clinical trial
Maurizio Angelo Leone, Maurizio Gelati, Daniela Celeste Profico, C Conti et autres
ABSTRACT Background Advanced cell therapeutics are emerging as potentially effective treatments for chronic neurological diseases, including secondary progressive multiple sclerosis (SPMS). Here we report the results of a phase I trial in which good manufacturing practice-grade foetal allogeneic human neural stem cells …
it, ch, gb (code pays fourni par la source)
3 citations
medRxiv